Navigation Links
Prostate cancer now detectable by imaging-guided biopsy
Date:12/10/2012

ow, with this new method that fuses MRI and ultrasound, we have the potential to see the prostate cancer and aim for it in a much more refined and rational manner."

The new targeting process is the result of four years of work funded by the National Cancer Institute and based in the Clark Urology Center at UCLA.

Since the mid-1980s, prostate cancer has been diagnosed using trans-rectal ultrasound to sample the prostate. Unlike most other cancers, prostate cancer is the only major malignancy diagnosed without actually visualizing the tumor as a biopsy is done, Marks said.

With the advent of sophisticated MRI, imaging the prostate improved and provided a picture of tumors within the organ. However, trying to biopsy the prostate with the patient inside the MRI has proved to be cumbersome, expensive and time consuming. Thus the fusion process evolved, permitting the targeted biopsy to be done in a clinic setting.

In this study, the volunteers undergo MRI first to visualize the prostate and any lesions. That information is then fed into a device called the Artemis, which fuses the MRI pictures with real-time, three-dimensional ultrasound, allowing the urologist to see the lesion during the biopsy.

"With the Artemis, we have a virtual map of the suspicious areas placed directly onto the ultrasound image during the biopsy," Marks said. "When you can see a lesion, you've got a major advantage of knowing what's really going on in the prostate. The results have been very dramatic, and the rate of cancer detection in these targeted biopsies is very high. We're finding a lot of tumors that hadn't been found before using conventional biopsies."

Prostate cancer was found in 53 percent of 171 study volunteers. Of those tumors found by the fusion biopsy technique, 38 percent had a Gleason score of greater than seven, which indicates an aggressive tumor, more likely to spread than tumors with lower scores. Once prostate cancer
'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-794-2262
University of California - Los Angeles Health Sciences
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Targeted prostate biopsy has potential to improve diagnosis of prostate cancer
2. The Project for Natural Health Choices Inc. Issues an Advisory for Men to Consume Flavonoids in their Diet to Protect Against Prostate Cancer
3. Targeted Prostate Cancer Biopsies Might Improve Care: Study
4. Longer life expectancy, aging population necessitate new strategies for prostate cancer care
5. Drug shows promise in prostate cancer spread to bone
6. Clinical trial at GHSU Cancer Center targets advanced prostate cancer
7. COUP-TFII sparks prostate cancer progression
8. UAlberta prostate cancer researcher and team developing homing beacon drugs to target cancer cells
9. Prostate Cancer Websites Often Hard to Understand: Study
10. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
11. New targeted therapy for advanced prostate cancer shows anti-tumor activity in clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... As the great passage beyond midlife gathers ... more substantial roles and connections that span the generations ... a life that still matters? As The Aspen Club ... Year Total Immersion Retreat , answers to these types ... and jump-starts a healthier life. A new round of ...
(Date:2/26/2015)... Imagine a day without access to clean, drinkable water ... was no one to help. For more than 783 million ... more than 2.5 billion people will also lack access to ... initiative led by Nevada’s Desert Research Institute (DRI) ... women – who often bear the brunt of the impact ...
(Date:2/26/2015)... NY (PRWEB) February 26, 2015 The ... with Topical BioMedics, Inc., Rhinebeck, NY, to offer customers ... creams—patented topical biomedicine formulas that safely and effectively address ... a new division of Vets Access LLC, Montrose, MI, ... and healing products. , Topical BioMedics is a research ...
(Date:2/26/2015)... Scotch Plains, NJ (PRWEB) February 26, 2015 ... celebrating the reopening of their newly renovated office in ... Mann, the Reproductive Science Center of New Jersey’s physicians, ... outstanding work and patient care in the areas of ... is commended for having excellent success rates and providing ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Beckman Coulter ... of extracellular vesicles and their cargo in cell-to-cell communication,” ... and their relevance for cell-to-cell communication. The webinar is ... 4, 2015 at 8:00am PT. , Every cell in ... vesicles (EVs) , often called “exosomes” or “microvesicles.” These ...
Breaking Medicine News(10 mins):Health News:The Aspen Club on Actively Aging: Telling a New Story on Aging 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3
... release are posted on the Mayo,Clinic News Blog: http://newsblog.mayoclinic.org/ ... for TV broadcast upon request., ROCHESTER, Minn. July 31 ... both men and women. For men,the record pace for the ... the 10,000-meter run just after World War II. Today, champion ...
... "open access" or free online, they get read more ... -- get cited more often in academic literature, finds ... student Philip Davis and colleagues, including three Cornell professors, ... access they need to relevant articles. , "It appears ...
... (Nasdaq:,EVVV) today announced that Pat Spangler, chief financial officer, ... at the,Canaccord Adams 28th Annual Global Growth Conference on ... Canaccord Adams 28th Annual Global,Growth Conference will be held ... the webcast, go to the investors, section of the ...
... 31 Halozyme Therapeutics,Inc. (Nasdaq: HALO ), ... extracellular matrix, today,announced that it will release financial ... 30, 2008 before market open on Friday, August ... Chief Executive Officer, Gregory Frost,PhD, Vice President and ...
... of Michigan to spray the state,s apple orchards with ... to treat blood infections in newborns and other serious ... America (IDSA). , The Environmental Protection Agency (EPA) ... to use gentamicin to fight a tree disease called ...
... Stereotaxis, Inc. (Nasdaq:,STXS) announced today that it ... ended June 30, 2008, on Tuesday, August 5, ... a conference call and webcast on,Tuesday, August 5, ... the Company,s,second quarter results and current corporate developments. ...
Cached Medicine News:Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 2Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 3Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 4Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 5Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 6Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 7Health News:Free articles get read but don't generate more citations 2Health News:Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8 2Health News:Physicians ask EPA, 'Antibiotics to cure sick apples, or sick children?' 2
(Date:2/26/2015)... -- ABIVAX, a clinical stage biotech company developing ... it has dosed in New Zealand ... ABX203 which is taking place in several countries of the ... to assess whether ABX203 can deliver a significant improvement in ... load for a much longer period of time when compared ...
(Date:2/26/2015)... Medtronic, Inc. (U.S.), St. Jude Medical, ... in the Saudi Arabia , ... expected to lead the market during the period of 2014 ... player in the market, and owns a wide product portfolio ... Entera Neurostimulator are some of the most popular brands of ...
(Date:2/26/2015)... --  HeartWare International, Inc . (NASDAQ: HTWR ... support technologies that are revolutionizing the treatment of advanced ... the fourth quarter ended December 31, 2014, a 38% ... same period of 2013.  For the fiscal year 2014, ... increase compared to revenue of $207.9 million in 2013.  ...
Breaking Medicine Technology:ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 2ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 3ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 4ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 5Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 2Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 3Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 4HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 2HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 3HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 4HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 5HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 6HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 7HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 8HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 9HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 10HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 11HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 12
... (OTCQB: ABHI), a leader in the development of wireless products ... a new line of credit with East West Bank, renewing ... July 2011. The new line of credit expands AmbiCom,s available ... revolving line and extends the line by one year to ...
... N.J., May 24, 2011 Systech International®, innovator ... our Brazilian Partner Videojet today announced that one ... to implement Systech,s Serialized Product Tracking (SPT) ... in Brazil.  The manufacturer will employ Systech SPT ...
Cached Medicine Technology:AmbiCom Renews and Expands Line of Credit With East West Bank 2AmbiCom Renews and Expands Line of Credit With East West Bank 3Top Pharmaceutical Manufacturer Selects Systech to Meet Brazil's Anti-Counterfeiting Regulatory Requirements 2Top Pharmaceutical Manufacturer Selects Systech to Meet Brazil's Anti-Counterfeiting Regulatory Requirements 3Top Pharmaceutical Manufacturer Selects Systech to Meet Brazil's Anti-Counterfeiting Regulatory Requirements 4
CRP Full Range (0.1-160mg/l)...
CRP Calibrator...
Fructosamine controls level 3...
Drug controls sera available in three levels for the control of accuracy and percision for up to 18 analytes...
Medicine Products: